@article{d3fe8db1156241499989692cc6cec1f0,
title = "The ethics of placebo controlled clinical trials in NMO - A balance of risks",
keywords = "Ethics, Neuromyelitis optica, Placebo-controlled trials",
author = "Michael Levy",
note = "Funding Information: Dr. Levy receives research support from NIH (Grant no. NS078555), Guthy Jackson Charitable Foundation , Viropharma , Acorda , Sanofi , NeuralStem and Genentech , and serves as a consultant for Chugai Pharmaceuticals, GlaxoSmithKline and Medimmune. Dr. Levy is also a paid consultant to Alexion Pharmaceuticals. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. ",
year = "2015",
month = nov,
doi = "10.1016/j.msard.2015.07.016",
language = "English (US)",
volume = "4",
pages = "512--514",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
publisher = "Elsevier",
number = "6",
}